Literature DB >> 33947777

Clinical Reasoning: A 59-Year-Old Woman Presenting With Diplopia, Dysarthria, Right-Sided Weakness, and Encephalopathy.

Giovanna S Manzano1, Matthew Torre2, Marlise R Luskin2, Henrikas Vaitkevicius2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33947777      PMCID： PMC9245924          DOI： 10.1212/WNL.0000000000012151

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   11.800


× No keyword cloud information.
  8 in total

Review 1.  Cytarabine and neurologic toxicity.

Authors:  W J Baker; G L Royer; R B Weiss
Journal:  J Clin Oncol       Date:  1991-04       Impact factor: 44.544

2.  PRES (posterior reversible encephalopathy syndrome), a rare complication of tacrolimus therapy.

Authors:  P Hodnett; J Coyle; K O'Regan; M M Maher; N Fanning
Journal:  Emerg Radiol       Date:  2008-12-19

3.  Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.

Authors:  Deepa Bhojwani; Noah D Sabin; Deqing Pei; Jun J Yang; Raja B Khan; John C Panetta; Kevin R Krull; Hiroto Inaba; Jeffrey E Rubnitz; Monika L Metzger; Scott C Howard; Raul C Ribeiro; Cheng Cheng; Wilburn E Reddick; Sima Jeha; John T Sandlund; William E Evans; Ching-Hon Pui; Mary V Relling
Journal:  J Clin Oncol       Date:  2014-02-18       Impact factor: 44.544

4.  Neurotoxicity of intrathecal methotrexate: MR imaging findings.

Authors:  Claudio Sandoval; Martin Kutscher; Somasundaram Jayabose; Michael Tenner
Journal:  AJNR Am J Neuroradiol       Date:  2003-10       Impact factor: 3.825

5.  Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer.

Authors:  H Inaba; R B Khan; F H Laningham; K R Crews; C-H Pui; N C Daw
Journal:  Ann Oncol       Date:  2007-10-17       Impact factor: 32.976

6.  Aminophylline for methotrexate-induced neurotoxicity.

Authors:  J C Bernini; D W Fort; J C Griener; B J Kane; W B Chappell; B A Kamen
Journal:  Lancet       Date:  1995-03-04       Impact factor: 79.321

Review 7.  Preventing and Managing Toxicities of High-Dose Methotrexate.

Authors:  Scott C Howard; John McCormick; Ching-Hon Pui; Randall K Buddington; R Donald Harvey
Journal:  Oncologist       Date:  2016-08-05

Review 8.  Evaluation, Identification, and Management of Acute Methotrexate Toxicity in High-dose Methotrexate Administration in Hematologic Malignancies.

Authors:  Doron Feinsilber; Roberto J Leoni; Duminda Siripala; Julianne Leuck; Katrina A Mears
Journal:  Cureus       Date:  2018-01-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.